Ribosomal proteins: Functions beyond the ribosome

Journal of Molecular Cell Biology

Volumn 7, Issue 2, 2015, Pages 92-104

  Zhou, Xiang ^a   Liao, Wen Juan ^a   Liao, Jun Ming ^a   Liao, Peng ^a   Lu, Hua ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; immunity; MDM2; p53; ribosomal protein; ribosomal stress; ribosomopathy

Indexed keywords

ONCOPROTEIN; PROTEIN P53; RIBOSOME PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BIOGENESIS; CARCINOGENESIS; CELL STRESS; HUMAN; IMMUNE RESPONSE; NEOPLASM; NONHUMAN; PROTEIN FUNCTION; RIBOSOMAL STRESS; RIBOSOME; ANIMAL; ANTIBODY SPECIFICITY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; NEOPLASMS; ONCOGENE PROTEINS; ORGAN SPECIFICITY; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84929849018     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjv014     Document Type: Article

References (198)

1. Allison, A.C., and Eugui, E.M. (2005). Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 80, S181-S190.
2. Anderson, S.J., Lauritsen, J.P., Hartman, M.G., et al. (2007). Ablation of ribosomal protein L22 selectively impairs ab T cell development by activation of a p53-dependent checkpoint. Immunity 26, 759-772.
3. Artero-Castro, A., Castellvi, J., Garcia, A., et al. (2011). Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors. Hum. Pathol. 42, 194-203.
4. Austin, K.M., Leary, R.J., and Shimamura, A. (2005). The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood 106, 1253-1258.
5. Bai, D., Zhang, J., Xiao,W., et al. (2014). Regulation of theHDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress. Nucleic Acids Res. 42, 1799-1811.
6. Barkic, M., Crnomarkovic, S., Grabusic, K., et al. (2009). The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival. Mol. Cell. Biol. 29, 2489-2504.
7. Barlow, J.L., Drynan, L.F., Hewett, D.R., et al. (2010). A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat. Med. 16, 59-66.
8. Barna, M., Pusic, A., Zollo, O., et al. (2008). Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456, 971-975.
9. Beyer, A.R., Bann, D.V., Rice, B., et al. (2013). Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9. J. Virol. 87, 1069-1082.
10. Bolze, A., Mahlaoui, N., Byun, M., et al. (2013). Ribosomal proteinSA haploinsufficiency in humans with isolated congenital asplenia. Science 340, 976-978.
11. Boria, I., Quarello, P., Avondo, F., et al. (2008). A new database for ribosomal protein genes which are mutated in Diamond-Blackfan anemia. Hum. Mutat. 29, E263-E270.
12. Boulon, S., Westman, B.J., Hutten, S., et al. (2010). The nucleolus under stress. Mol. Cell 40, 216-227.
13. Burger, K., Muhl, B., Harasim, T., et al. (2010). Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J. Biol. Chem. 285, 12416-12425.
14. Bywater, M.J., Poortinga, G., Sanij, E., et al. (2012). Inhibition of RNA polymerase I as atherapeutic strategy to promotecancer-specific activation of p53. Cancer Cell 22, 51-65.
15. Cairns, C.A., and White, R.J. (1998). p53 is a general repressor ofRNA polymerase III transcription. EMBO J. 17, 3112-3123.
16. Campagnoli, M.F., Ramenghi, U., Armiraglio, M., et al. (2008). RPS19 mutations in patients with Diamond-Blackfan anemia. Hum. Mutat. 29, 911-920.
17. Cardenas, M.E., Cutler, N.S., Lorenz, M.C., et al. (1999). The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev. 13, 3271-3279.
18. Cavanaugh, A.H., Hempel, W.M., Taylor, L.J., et al. (1995). Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature 374, 177-180.
19. Challagundla, K.B., Sun, X.X., Zhang, X., et al. (2011). Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol. Cell. Biol. 31, 4007-4021.
20. Chen, W., and Dittmer, D.P. (2011). Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 85, 9495-9505.
21. Chen, D., Zhang, Z., Li, M., et al. (2007). Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding toMDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 26, 5029-5037.
22. Chen, B., Zhang, W., Gao, J., et al. (2014). Downregulation of ribosomal protein S6 inhibits the growth of non-small cell lung cancer by inducing cell cycle arrest, rather than apoptosis. Cancer Lett. 354, 378-389.
23. Cheng, E., Haque, A., Rimmer, M.A., et al. (2011). Characterization of the Interaction between hantavirus nucleocapsid protein (N) and ribosomal protein S19 (RPS19). J. Biol. Chem. 286, 11814-11824.
24. Ciarmatori, S., Scott, P.H., Sutcliffe, J.E., et al. (2001). Overlapping functions of the pRb family in the regulation of rRNA synthesis. Mol. Cell. Biol. 21, 5806-5814.
25. Claypool, J.A., French, S.L., Johzuka, K., et al. (2004). Tor pathway regulates Rrn3p-dependent recruitment of yeast RNA polymerase I to the promoter but does not participate in alteration of the number of active genes. Mol. Biol. Cell 15, 946-956.
26. Cmejla, R., Cmejlova, J., Handrkova, H., et al. (2007). Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum. Mutat. 28, 1178-1182.
27. Cmejla, R., Cmejlova, J., Handrkova, H., et al. (2009). Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia. Hum. Mutat. 30, 321-327.
28. Cordon-Cardo, C., and Reuter, V.E. (1997). Alterations of tumor suppressor genes in bladder cancer. Semin. Diagn. Pathol. 14, 123-132.
29. Cui, D., Li, L., Lou, H., et al. (2014). The ribosomal protein S26 regulates p53 activity in response to DNA damage. Oncogene 33, 2225-2235.
30. Daftuar, L., Zhu, Y., Jacq, X., et al. (2013). Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS One 8, e68667.
31. Dai, M.S., and Lu, H. (2004). Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 279, 44475-44482.
32. Dai, M.S., and Lu, H. (2008). Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J. Cell. Biochem. 105, 670-677.
33. Dai, M.S., Zeng, S.X., Jin, Y., et al. (2004). Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol. Cell. Biol. 24, 7654-7668.
34. Dai, M.S., Arnold, H., Sun, X.X., et al. (2007). Inhibition of c-Myc activity by ribosomal protein L11. EMBO J. 26, 3332-3345.
35. Dai, M.S., Sun, X.X., and Lu, H. (2008). Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol. Cell. Biol. 28, 4365-4376.
36. Dai, Y., Pierson, S.E., Dudney, W.C., et al. (2010). Extraribosomal function of metallopanstimulin-1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth. Int. J. Cancer 126, 611-619.
37. Dai, Y., Pierson, S., Dudney, C., et al. (2011). Ribosomal protein metallopanstimulin-1 impairs multiple myelomaCAGcells growth and inhibits fibroblast growth factor receptor 3. Clin. Lymphoma Myeloma Leuk. 11, 490-497.
38. De Keersmaecker, K., Atak, Z.K., Li, N., et al. (2013). Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat. Genet. 45, 186-190.
39. de Las Heras-Rubio, A., Perucho, L., Paciucci, R., et al. (2014). Ribosomal proteins as novel players in tumorigenesis. Cancer Metastasis Rev. 33, 115-141.
40. Doherty, L., Sheen, M.R., Vlachos, A., et al. (2010). Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am. J. Hum. Genet. 86, 222-228.
41. Donati, G., Peddigari, S., Mercer, C.A., et al. (2013). 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep. 4, 87-98.
42. Draptchinskaia, N., Gustavsson, P., Andersson, B., et al. (1999). The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet. 21, 169-175.
43. Drygin, D., Siddiqui-Jain, A., O'Brien, S., et al. (2009). Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res. 69, 7653-7661.
44. Drygin, D., Lin, A., Bliesath, J., et al. (2011). Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomalRNAsynthesis and solid tumor growth. Cancer Res. 71, 1418-1430.
45. Duan, J., Ba, Q., Wang, Z., et al. (2011). Knockdown of ribosomal protein S7 causes developmental abnormalities via p53 dependent and independent pathways in zebrafish. Int. J. Biochem. Cell Biol. 43, 1218-1227.
46. Duncan, K.A., Jimenez, P., and Carruth, L.L. (2009). The selective estrogen receptor-a coactivator, RPL7, and sexual differentiation of the songbird brain. Psychoneuroendocrinology 34(Suppl 1), S30-S38.
47. Dutt, S., Narla, A., Lin, K., et al. (2011). Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 117, 2567-2576.
48. Ebert, B.L., Pretz, J., Bosco, J., et al. (2008). Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 451, 335-339.
49. Ellis, S.R. (2014). Nucleolar stress in Diamond Blackfan anemia pathophysiology. Biochim. Biophys. Acta 1842, 765-768.
50. Farrar, J.E., Nater, M., Caywood, E., et al. (2008). Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 112, 1582-1592.
51. Fatica, A., and Tollervey, D. (2002). Making ribosomes. Curr. Opin. Cell Biol. 14, 313-318.
52. Filip, A.M., Klug, J., Cayli, S., et al. (2009). Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function. J. Biol. Chem. 284, 7977-7985.
53. Fregoso, O.I., Das, S., Akerman, M., et al. (2013). Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence. Mol. Cell 50, 56-66.
54. Fumagalli, S., Di Cara, A., Neb-Gulati, A., et al. (2009). Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell Biol. 11, 501-508.
55. Fumagalli, S., Ivanenkov, V.V., Teng, T., et al. (2012). Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev. 26, 1028-1040.
56. Ganapathi, K.A., Austin, K.M., Lee, C.S., et al. (2007). The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood 110, 1458-1465.
57. Gao, X., and Hardwidge, P.R. (2011). Ribosomal protein s3: a multifunctional target of attaching/effacing bacterial pathogens. Front. Microbiol. 2, 137.
58. Gao, X., Wan, F., Mateo, K., et al. (2009). Bacterial effector binding to ribosomal protein s3 subverts NF-kB function. PLoS Pathog. 5, e1000708.
59. Gao, M., Li, X., Dong, W., et al. (2013). Ribosomal protein S7 regulates arsenite-induced GADD45a expression by attenuating MDM2-mediated GADD45aubiquitination and degradation. Nucleic Acids Res. 41, 5210-5222.
60. Garcon, L., Ge, J., Manjunath, S.H., et al. (2013). Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood 122, 912-921.
61. Gazda, H.T., Grabowska, A., Merida-Long, L.B., et al. (2006). Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am. J. Hum. Genet. 79, 1110-1118.
62. Gazda, H.T., Sheen, M.R., Vlachos, A., et al. (2008). Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 83, 769-780.
63. Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-kB puzzle. Cell 109(Suppl), S81-S96.
64. Ghoshal, K., and Jacob, S.T. (1994). Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil. Cancer Res. 54, 632-636.
65. Green, L., Houck-Loomis, B., Yueh, A., et al. (2012). Large ribosomal protein 4 increases efficiency of viral recoding sequences. J. Virol. 86, 8949-8958.
66. Gripp, K.W., Curry, C., Olney, A.H., et al. (2014). Diamond-Blackfan anemia with mandibulofacial dysostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28. Am. J. Med. Genet. A 164A, 2240-2249.
67. Guan, H., Hou, S., and Ricciardi, R.P. (2005). DNA binding of repressor nuclear factor-kB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J. Biol. Chem. 280, 9957-9962.
68. Guerra-Rebollo, M., Mateo, F., Franke, K., et al. (2012). Nucleolar exit ofRNF8 and BRCA1 in response to DNA damage. Exp. Cell Res. 318, 2365-2376.
69. Guo, X., Shi, Y., Gou, Y., et al. (2011). Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1). J. Cell. Mol. Med. 15, 296-306.
70. Hannan, K.M., Hannan, R.D., Smith, S.D., et al. (2000). Rb and p130 regulateRNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1. Oncogene 19, 4988-4999.
71. Hannan, K.M., Brandenburger, Y., Jenkins, A., et al. (2003). mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated byphosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol. Cell. Biol. 23, 8862-8877.
72. Haque, A., and Mir, M.A. (2010). Interaction of hantavirus nucleocapsid protein with ribosomal protein S19. J. Virol. 84, 12450-12453.
73. Hertz, M.I., Landry, D.M., Willis, A.E., et al. (2013). Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting. Mol. Cell. Biol. 33, 1016-1026.
74. Hoppe, S., Bierhoff, H., Cado, I., et al. (2009). AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc. Natl Acad. Sci. USA 106, 17781-17786.
75. Horn, H.F., and Vousden, K.H. (2008). Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 27, 5774-5784.
76. Horos, R., Ijspeert, H., Pospisilova, D., et al. (2012). Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood 119, 262-272.
77. Huang, J.Y., Su, W.C., Jeng, K.S., et al. (2012). Attenuation of 40S ribosomal subunit abundance differentially affects host and HCV translation and suppresses HCV replication. PLoS Pathog. 8, e1002766.
78. Iapalucci-Espinoza, S., and Franze-Fernandez, M.T. (1979). Effect of protein synthesis inhibitors and low concentrations of actinomycin D on ribosomal RNA synthesis. FEBS Lett. 107, 281-284.
79. Iizumi, Y., Oishi, M., Taniguchi, T., et al. (2013). The flavonoid apigenin downregulates CDK1 by directly targeting ribosomal protein S9. PLoS One 8, e73219.
80. Jaako, P., Flygare, J., Olsson, K., et al. (2011). Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 118, 6087-6096.
81. Jang, C.Y., Kim, H.D., and Kim, J. (2012). Ribosomal protein S3 interacts with TRADD to induce apoptosis through caspase dependent JNK activation. Biochem. Biophys. Res. Commun. 421, 474-478.
82. Jia, J., Arif, A., Willard, B., et al. (2012). Protection of extraribosomal RPL13a by GAPDH and dysregulation by S-nitrosylation. Mol. Cell 47, 656-663.
83. Jin, A., Itahana, K., O'Keefe, K., et al. (2004). Inhibition ofHDM2 and activation of p53 by ribosomal protein L23. Mol. Cell. Biol. 24, 7669-7680.
84. Jordan, P., and Carmo-Fonseca, M. (1998). Cisplatin inhibits synthesis of ribosomal RNA in vivo. Nucleic Acids Res. 26, 2831-2836.
85. Jorgensen, P., Nishikawa, J.L., Breitkreutz, B.J., et al. (2002). Systematic identification of pathways that couple cell growth and division in yeast. Science 297, 395-400.
86. Jorgensen, P., Rupes, I., Sharom, J.R., et al. (2004). A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 18, 2491-2505.
87. Kandoth, C., McLellan, M.D., Vandin, F., et al. (2013). Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339.
88. Khalaileh, A., Dreazen, A., Khatib, A., et al. (2013). Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. Cancer Res. 73, 1811-1820.
89. Kirn-Safran, C.B., Oristian, D.S., Focht, R.J., et al. (2007). Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev. Dyn. 236, 447-460.
90. Klauck, S.M., Felder, B., Kolb-Kokocinski, A., et al. (2006). Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol. Psychiatry 11, 1073-1084.
91. Kondoh, N., Shuda, M., Tanaka, K., et al. (2001). Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Anticancer Res. 21, 2429-2433.
92. Kondrashov, N., Pusic, A., Stumpf, C.R., et al. (2011). Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 145, 383-397.
93. Kraft, C., Deplazes, A., Sohrmann, M., et al. (2008). Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease. Nat. Cell Biol. 10, 602-610.
94. Kruhlak, M., Crouch, E.E., Orlov, M., et al. (2007). The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature 447, 730-734.
95. Kuroda, K., Takenoyama, M., Baba, T., et al. (2010). Identification of ribosomal protein L19 as a novel tumor antigen recognized by autologous cytotoxic T lymphocytes in lung adenocarcinoma. Cancer Sci. 101, 46-53.
96. Lam, Y.W., Lamond, A.I., Mann, M., et al. (2007). Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr. Biol. 17, 749-760.
97. Lambertsson, A. (1998). The minute genes in Drosophila and their molecular functions. Adv. Genet. 38, 69-134.
98. Landowski, M., O'Donohue, M.F., Buros, C., et al. (2013). Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Hum. Genet. 132, 1265-1274.
99. Landry, D.M., Hertz, M.I., and Thompson, S.R. (2009). RPS25 is essential for translation initiation by the Dicistroviridae and hepatitis C viral IRESs. Genes Dev. 23, 2753-2764.
100. Lee, S.B., Kwon, I.S., Park, J., et al. (2010). Ribosomal proteinS3, a newsubstrate of Akt, serves as a signal mediator between neuronal apoptosis and DNA repair. J. Biol. Chem. 285, 29457-29468.
101. Lee, A.S., Burdeinick-Kerr, R., and Whelan, S.P. (2013). A ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAs. Proc. Natl Acad. Sci. USA 110, 324-329.
102. Liao, J.M., Zhou, X., Gatignol, A., et al. (2013). Ribosomal proteins L5 and L11 cooperatively inactivate c-Myc via RNA-induced silencing complex. Oncogene 33, 4916-4923.
103. Lim, K.H., Kim, K.H., Choi, S.I., et al. (2011). RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-kB signaling via its novel chaperoning function. PLoS One 6, e22258.
104. Lindstrom, M.S., Jin, A., Deisenroth, C., et al. (2007). Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol. Cell. Biol. 27, 1056-1068.
105. Llanos, S., and Serrano, M. (2010). Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway. Cell Cycle 9, 4005-4012.
106. Lohrum, M.A., Ludwig, R.L., Kubbutat, M.H., et al. (2003). Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3, 577-587.
107. Lopez-Diaz, F.J., Gascard, P., Balakrishnan, S.K., et al. (2013). Coordinate transcriptional and translational repression of p53 by TGF-b1 impairs the stress response. Mol. Cell 50, 552-564.
108. Lv, J., Huang, X.R., Klug, J., et al. (2013). Ribosomal protein S19 is a novel therapeutic agent in inflammatory kidney disease. Clin. Sci. (Lond) 124, 627-637.
109. Macias, E., Jin, A., Deisenroth, C., et al. (2010). An ARF-independent c-MYCactivated tumor suppression pathway mediated by ribosomal protein- Mdm2 Interaction. Cancer Cell 18, 231-243.
110. Marechal, V., Elenbaas, B., Piette, J., et al. (1994). The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14, 7414-7420.
111. Marion, R.M., Regev, A., Segal, E., et al. (2004). Sfp1 is a stress- and nutrient-sensitive regulator of ribosomal protein gene expression. Proc. Natl Acad. Sci. USA 101, 14315-14322.
112. Martin, D.E., Soulard, A., and Hall, M.N. (2004). TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1. Cell 119, 969-979.
113. Martin, I., Kim, J.W., Lee, B.D., et al. (2014). Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell 157, 472-485.
114. Matsson, H., Davey, E.J., Draptchinskaia, N., et al. (2004). Targeted disruption of the ribosomal protein S19 gene is lethal prior to implantation. Mol. Cell. Biol. 24, 4032-4037.
115. Mayer, C., and Grummt, I. (2006). Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 25, 6384-6391.
116. Mayer, C., Zhao, J., Yuan, X., et al. (2004). mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev. 18, 423-434.
117. Mazumder, B., Sampath, P., Seshadri, V., et al. (2003). Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell 115, 187-198.
118. McGowan, K.A., Li, J.Z., Park, C.Y., et al. (2008). Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat. Genet. 40, 963-970.
119. Menne, T.F., Goyenechea, B., Sanchez-Puig, N., et al. (2007). The Shwachman- Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat. Genet. 39, 486-495.
120. Meyuhas, O. (2000). Synthesis of the translational apparatus is regulated at the translational level. Eur. J. Biochem. 267, 6321-6330.
121. Miller, S.A., Brown, A.J., Farach-Carson, M.C., et al. (2003). HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation 71, 322-336.
122. Mirabello, L., Macari, E.R., Jessop, L., et al. (2014). Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families. Blood 124, 24-32.
123. Morgado-Palacin, L., Llanos, S., and Serrano, M. (2012). Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells. Cell Cycle 11, 503-510.
124. Mukhopadhyay, R., Ray, P.S., Arif, A., et al. (2008). DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression. Mol. Cell 32, 371-382.
125. Mukhopadhyay, R., Jia, J., Arif, A., et al. (2009). The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem. Sci. 34, 324-331.
126. Naora, H., Takai, I., and Adachi, M. (1998). Altered cellular responses by varying expression of a ribosomal protein gene: sequential coordination of enhancement and suppression of ribosomal protein S3a gene expression induces apoptosis. J. Cell Biol. 141, 741-753.
127. Narla, A., and Ebert, B.L. (2010). Ribosomopathies: human disorders of ribosome dysfunction. Blood 115, 3196-3205.
128. Nishiyama, T., Yamamoto, H., Uchiumi, T., et al. (2007). Eukaryotic ribosomal protein RPS25 interacts with the conserved loop region in a dicistroviral intergenic internal ribosome entry site. Nucleic Acids Res. 35, 1514-1521.
129. Ofir-Rosenfeld, Y., Boggs, K., Michael, D., et al. (2008). Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol. Cell 32, 180-189.
130. Olivares, E., Landry, D.M., Caceres, C.J., et al. (2014). The 5'untranslated region of the human T-cell lymphotropic virus type 1mRNAenables cap-independent translation initiation. J. Virol. 88, 5936-5955.
131. Oristian, D.S., Sloofman, L.G., Zhou, X., et al. (2009). Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. J. Orthop. Res. 27, 28-35.
132. Perry, R.P., and Kelley, D.E. (1970). Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. J. Cell. Physiol. 76, 127-139.
133. Perucho, L., Artero-Castro, A., Guerrero, S., et al. (2014). RPLP1, a crucial ribosomal protein for embryonic development of the nervous system. PLoS One 9, e99956.
134. Plaksin, D., Baeuerle, P.A., and Eisenbach, L. (1993). KBF1 (p50 NF-kB homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells. J. Exp. Med. 177, 1651-1662.
135. Provost, E., Wehner, K.A., Zhong, X., et al. (2012). Ribosomal biogenesis genes play an essential and p53-independent role in zebrafish pancreas development. Development 139, 3232-3241.
136. Provost, E., Weier, C.A., and Leach, S.D. (2013). Multiple ribosomal proteins are expressed at high levels in developing zebrafish endoderm and are required for normal exocrine pancreas development. Zebrafish 10, 161-169.
137. Rao, S., Lee, S.Y., Gutierrez, A., et al. (2012). Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood 120, 3764-3773.
138. Ray, P.S., and Fox, P.L. (2007). A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity. EMBO J. 26, 3360-3372.
139. Romanova, L., Grand, A., Zhang, L., et al. (2009). Critical role of nucleostemin in pre-rRNA processing. J. Biol. Chem. 284, 4968-4977.
140. Rubbi, C.P., and Milner, J. (2003). Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22, 6068-6077.
141. Rudra, D., Zhao, Y., and Warner, J.R. (2005). Central role of Ifh1p-Fhl1p interaction in the synthesis of yeast ribosomal proteins. EMBO J. 24, 533-542.
142. Ruggero, D., and Pandolfi, P.P. (2003). Does the ribosome translate cancer? Nat. Rev. Cancer 3, 179-192.
143. Saeboe-Larssen, S., Lyamouri, M., Merriam, J., et al. (1998). Ribosomal protein insufficiency and the minute syndrome in Drosophila: a dose-response relationship. Genetics 148, 1215-1224.
144. Sampath, P., Mazumder, B., Seshadri, V., et al. (2004). Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation. Cell 119, 195-208.
145. Sasaki, M., Kawahara, K., Nishio, M., et al. (2011). Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat. Med. 17, 944-951.
146. Schawalder, S.B., Kabani, M., Howald, I., et al. (2004). Growth-regulated recruitment of the essential yeast ribosomal protein gene activator Ifh1. Nature 432, 1058-1061.
147. Sen, N., Paul, B.D., Gadalla, M.M., et al. (2012). Hydrogen sulfide-linked sulfhydration of NF-kB mediates its antiapoptotic actions. Mol. Cell 45, 13-24.
148. Shi, Y., Zhai, H., Wang, X., et al. (2004). Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp. Cell Res. 296, 337-346.
149. Shi, W., Zhang, X., Jiang, X., et al. (2011). Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science 333, 1630-1632.
150. Shuda, M., Kondoh, N., Tanaka, K., et al. (2000). Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res. 20, 2489-2494.
151. Silvera, D., Formenti, S.C., and Schneider, R.J. (2010). Translational control in cancer. Nat. Rev. Cancer 10, 254-266.
152. Smolock, E.M., Korshunov, V.A., Glazko, G., et al. (2012). Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation. Circulation 126, 2418-2427.
153. Sun, X.X., Dai, M.S., and Lu, H. (2007). 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. J. Biol. Chem. 282, 8052-8059.
154. Sun, X.X., Dai, M.S., and Lu, H. (2008). Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11. J. Biol. Chem. 283, 12387-12392.
155. Sun, X.X., Wang, Y.G., Xirodimas, D.P., et al. (2010). Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation. J. Biol. Chem. 285, 25812-25821.
156. Sun, X.X., DeVine, T., Challagundla, K.B., et al. (2011). Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress. J. Biol. Chem. 286, 22730-22741.
157. Sutcliffe, J.E., Brown, T.R., Allison, S.J., et al. (2000). Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription. Mol. Cell. Biol. 20, 9192-9202.
158. Takagi, M., Absalon, M.J., McLure, K.G., et al. (2005). Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123, 49-63.
159. Taylor, A.M., Humphries, J.M., White, R.M., et al. (2012). Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation. Exp. Hematol. 40, 228-237 e225.
160. Terzian, T., Dumble, M., Arbab, F., et al. (2011). Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models. J. Pathol. 224, 540-552.
161. Tsai, R.Y., and McKay, R.D. (2005). A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J. Cell Biol. 168, 179-184.
162. Tschochner, H., and Hurt, E. (2003). Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends Cell Biol. 13, 255-263.
163. Tsofack, S.P., Meunier, L., Sanchez, L., et al. (2013). Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis. BMC Cancer 13, 303.
164. van Riggelen, J., Yetil, A., and Felsher, D.W. (2010). MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 10, 301-309.
165. Volarevic, S., Stewart, M.J., Ledermann, B., et al. (2000). Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288, 2045-2047.
166. Vyas, K., Chaudhuri, S., Leaman,D.W., et al. (2009). Genome-wide polysome profiling reveals an inflammation-responsive posttranscriptional operon in g interferon-activated monocytes. Mol. Cell. Biol. 29, 458-470.
167. Wan, F., Anderson, D.E., Barnitz, R.A., et al. (2007). Ribosomal protein S3: a KH domain subunit in NF-kB complexes that mediates selective gene regulation. Cell 131, 927-939.
168. Wan, F., Weaver, A., Gao, X., et al. (2011). IKKb phosphorylation regulates RPS3 nuclear translocation and NF-kB function during infection with Escherichia coli strain O157:H7. Nat. Immunol. 12, 335-343.
169. Wang, A., Xu, S., Zhang, X., et al. (2011). Ribosomal protein RPL41 induces rapid degradation of ATF4, a transcription factor critical for tumour cell survival in stress. J. Pathol. 225, 285-292.
170. Wang, Z., Hou, J., Lu, L., et al. (2013). Small ribosomal protein subunit S7 suppresses ovarian tumorigenesis through regulation of the PI3K/AKT and MAPK pathways. PLoS One 8, e79117.
171. Wang, L., Luo, J., Nian, Q., et al. (2014). Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53. Hematology 19, 225-231.
172. Wang, W., Nag, S., Zhang, X., et al. (2015). Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Med. Res. Rev. 35, 225-285.
173. Wanzel, M., Russ, A.C., Kleine-Kohlbrecher, D., et al. (2008). A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat. Cell Biol. 10, 1051-1061.
174. Warner, J.R., and McIntosh, K.B. (2009). How common are extraribosomal functions of ribosomal proteins? Mol. Cell 34, 3-11.
175. Watkins-Chow, D.E., Cooke, J., Pidsley, R., et al. (2013). Mutation of the diamondblackfan anemia gene Rps7 in mouse results in morphological and neuroanatomical phenotypes. PLoS Genet. 9, e1003094.
176. White, R.J., Trouche, D., Martin, K., et al. (1996). Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 382, 88-90.
177. Wood, J., Frederickson, R.M., Fields, S., et al. (2001). Hepatitis C virus 3'X region interacts with human ribosomal proteins. J. Virol. 75, 1348-1358.
178. Xiong, X., Zhao, Y., He, H., et al. (2011). Ribosomal proteinS27-likeandS27interplay with p53-MDM2 axis as a target, a substrate and a regulator. Oncogene 30, 1798-1811.
179. Xiong, X., Zhao, Y., Tang, F., et al. (2014). Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis. Elife 3, e02236.
180. Yadavilli, S., Mayo, L.D., Higgins, M., et al. (2009). Ribosomal proteinS3: A multifunctional protein that interacts with both p53 and MDM2 through its KH domain. DNA Repair 8, 1215-1224.
181. Yang, Z.Y., Qu, Y., Zhang, Q., et al. (2012). Knockdown of metallopanstimulin-1 inhibits NF-kB signaling at different levels: the role of apoptosis induction of gastric cancer cells. Int. J. Cancer 130, 2761-2770.
182. Yang, H.J., Youn, H., Seong, K.M., et al. (2013a). Phosphorylation of ribosomal protein S3 and antiapoptotic TRAF2 protein mediates radioresistance in nonsmall cell lung cancer cells. J. Biol. Chem. 288, 2965-2975.
183. Yang, Z.Y., Jiang, H., Qu, Y., et al. (2013b). Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin b4. Carcinogenesis 34, 2851-2860.
184. Zaragoza, D., Ghavidel, A., Heitman, J., et al. (1998). Rapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway. Mol. Cell. Biol. 18, 4463-4470.
185. Zatsepina, O.V., Voronkova, L.N., Sakharov, V.N., et al. (1989). Ultrastructural changes in nucleoli and fibrillar centers under the effect of local ultraviolet microbeam irradiation of interphase culture cells. Exp. Cell Res. 181, 94-104.
186. Zhai,W., and Comai, L. (2000). Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol. Cell. Biol. 20, 5930-5938.
187. Zhang, Y., and Lu, H. (2009). Signaling to p53: ribosomal proteins find their way. Cancer Cell 16, 369-377.
188. Zhang, Y., Wolf, G.W., Bhat, K., et al. (2003). Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomalstress checkpoint pathway. Mol. Cell. Biol. 23, 8902-8912.
189. Zhang, S., Shi, M., Hui, C.C., et al. (2006). Loss of the mouse ortholog of the Shwachman-Diamond syndrome gene (Sbds) results in early embryonic lethality. Mol. Cell. Biol. 26, 6656-6663.
190. Zhang, Y., Wang, J., Yuan, Y., et al. (2010). Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26. Nucleic Acids Res. 38, 6544-6554.
191. Zhang, H.X., Liu, Z.X., Sun, Y.P., et al. (2013a). Rig-I regulates NF-kB activity through binding to Nf-kb1 3'-UTR mRNA. Proc. Natl Acad. Sci. USA 110, 6459-6464.
192. Zhang, X., Wang,W., Wang, H., et al. (2013b). Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Oncogene 32, 2782-2791.
193. Zhou, C., Zang, D., Jin, Y., et al. (2011). Mutation in ribosomal protein L21 underlies hereditary hypotrichosis simplex. Hum. Mutat. 32, 710-714.
194. Zhou, X., Liao, J.M., Liao, W.J., et al. (2012). Scission of the p53-MDM2 Loop by Ribosomal Proteins. Genes Cancer 3, 298-310.
195. Zhou, X., Hao, Q., Liao, J., et al. (2013a). Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene 32, 388-396.
196. Zhou, X., Hao, Q., Liao, J.M., et al. (2013b). Ribosomal proteinS14 negatively regulates c-Myc activity. J. Biol. Chem. 288, 21793-21801.
197. Zhou, X., Hao, Q., Zhang, Q., et al. (2014). Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition. Cell Death Differ. 22, 755-766.
198. Zhu, Y., Poyurovsky, M.V., Li, Y., et al. (2009). Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol. Cell 35, 316-326.